Literature DB >> 11830455

Up-regulation of the chemokine receptor CCR7 in classical but not in lymphocyte-predominant Hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs.

Uta E Höpken1, Hans-Dieter Foss, Dagmar Meyer, Michael Hinz, Korinna Leder, Harald Stein, Martin Lipp.   

Abstract

Chemokines and chemokine receptors are key mediators for regulating cell traffic and positioning in both homeostatic and inflammatory conditions. It is also presumed that chemokines and their receptors are likely to play a critical role in the localization of malignant hematopoietic cells in their target organs. This study analyzed chemokine and chemokine receptor expression in several Hodgkin disease (HD)-derived cell lines and in HD tumors. All HD-derived cell lines expressed functional CCR7 and CXCR4 receptors. CCR7 up-regulation was mediated by constitutive NF-kappaB activity. Lymphoid tissues in HD revealed differential expression levels of CCR7, CXCR4, and CXCR5, depending on the distinct subtypes of HD. HD of the classical subtypes, predominantly located in the interfollicular zone, showed strong CCR7 and CXCR4 expression and moderate CXCR5 expression. In contrast, the nodular lymphocyte-predominant HD (NLP) subtype, regularly associated with follicular structures, exhibited no CCR7 reactivity but abundant CXCR4 staining. Their respective chemokine ligands showed marked expression by reactive cells within the tumors of classical HD and outside of the tumor nodules in NLPHD. Functionally, such differential chemokine receptor expression might contribute to specific localization and confinement of neoplastic cells within the target organs in the distinct HD entities.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11830455     DOI: 10.1182/blood.v99.4.1109

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

1.  PAX5 overexpression is not enough to reestablish the mature B-cell phenotype in classical Hodgkin lymphoma.

Authors:  L Dimitrova; V Seitz; J Hecht; D Lenze; P Hansen; M Szczepanowski; L Ma; E Oker; A Sommerfeld; F Jundt; W Klapper; M Hummel
Journal:  Leukemia       Date:  2013-07-11       Impact factor: 11.528

2.  WNT5A: a motility-promoting factor in Hodgkin lymphoma.

Authors:  F Linke; S Zaunig; M M Nietert; F von Bonin; S Lutz; C Dullin; P Janovská; T Beissbarth; F Alves; W Klapper; V Bryja; T Pukrop; L Trümper; J Wilting; D Kube
Journal:  Oncogene       Date:  2016-06-06       Impact factor: 9.867

3.  Dual-action CXCR4-targeting liposomes in leukemia: function blocking and drug delivery.

Authors:  Catriona McCallion; Anna D Peters; Andrew Booth; Karen Rees-Unwin; Julie Adams; Raisa Rahi; Alain Pluen; Claire V Hutchinson; Simon J Webb; John Burthem
Journal:  Blood Adv       Date:  2019-07-23

4.  Chemokine receptor 7 (CCR7) gene expression is regulated by NF-κB and activator protein 1 (AP1) in metastatic squamous cell carcinoma of head and neck (SCCHN).

Authors:  Yvonne K Mburu; Ann Marie Egloff; William H Walker; Lin Wang; Raja R Seethala; Carter van Waes; Robert L Ferris
Journal:  J Biol Chem       Date:  2011-12-12       Impact factor: 5.157

5.  Microenvironmental interactions between endothelial and lymphoma cells: a role for the canonical WNT pathway in Hodgkin lymphoma.

Authors:  F Linke; M Harenberg; M M Nietert; S Zaunig; F von Bonin; A Arlt; M Szczepanowski; H A Weich; S Lutz; C Dullin; P Janovská; M Krafčíková; L Trantírek; P Ovesná; W Klapper; T Beissbarth; F Alves; V Bryja; L Trümper; J Wilting; D Kube
Journal:  Leukemia       Date:  2016-08-18       Impact factor: 11.528

6.  Epigenetic control of Ccr7 expression in distinct lineages of lung dendritic cells.

Authors:  Timothy P Moran; Hideki Nakano; Hrisavgi D Kondilis-Mangum; Paul A Wade; Donald N Cook
Journal:  J Immunol       Date:  2014-10-08       Impact factor: 5.422

7.  Profiling of Hodgkin's lymphoma cell line L1236 and germinal center B cells: identification of Hodgkin's lymphoma-specific genes.

Authors:  Ines Schwering; Andreas Bräuninger; Verena Distler; Julia Jesdinsky; Volker Diehl; Martin-Leo Hansmann; Klaus Rajewsky; Ralf Küppers
Journal:  Mol Med       Date:  2003 Mar-Apr       Impact factor: 6.354

8.  Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B.

Authors:  Stephan Mathas; Michael Hinz; Ioannis Anagnostopoulos; Daniel Krappmann; Andreas Lietz; Franziska Jundt; Kurt Bommert; Fatima Mechta-Grigoriou; Harald Stein; Bernd Dörken; Claus Scheidereit
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

9.  Impaired lymphoid chemokine-mediated migration due to a block on the chemokine receptor switch in human cytomegalovirus-infected dendritic cells.

Authors:  Magdalena Moutaftsi; Paul Brennan; Stephen A Spector; Zsuzsanna Tabi
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

10.  LSD1 Cooperates with Noncanonical NF-κB Signaling to Regulate Marginal Zone B Cell Development.

Authors:  Robert R Haines; Christopher D Scharer; Jenna L Lobby; Jeremy M Boss
Journal:  J Immunol       Date:  2019-09-06       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.